Sintx Technologies (SINT) Total Non-Current Liabilities (2013 - 2026)

Sintx Technologies' (SINT) quarterly Total Non-Current Liabilities came in at $6.4 million in Q1 2026, up 22.67% year-on-year from $5.2 million in Q1 2025, and up 11.7% quarter-over-quarter from $5.8 million in Q4 2025.

Sintx Technologies (SINT) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

Sintx Technologies' Total Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $6.4 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 22.67% year-over-year to $6.4 million in Q1 2026; TTM through Mar 2026 was $6.4 million, a 22.67% increase from a year earlier, with the FY2025 full-year figure at $5.8 million, up 8.27% from the prior year.
  • Total Non-Current Liabilities advanced to $6.4 million in Q1 2026 per SINT's latest filing, from $5.8 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $10.1 million in Q4 2022 and bottomed at $4.1 million in Q1 2022.
  • The 5-year median for Total Non-Current Liabilities is $5.7 million (2024), against an average of $6.0 million.
  • Across the five-year window, Total Non-Current Liabilities surged 134.23% in 2022 and slumped 37.53% in 2023, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $10.1 million in 2022, then slumped by 37.53% to $6.3 million in 2023, then decreased by 15.55% to $5.3 million in 2024, then grew by 8.27% to $5.8 million in 2025, then climbed by 11.7% to $6.4 million in 2026.
  • Per Business Quant, the three latest SINT Total Non-Current Liabilities figures stand at $6.4 million (Q1 2026), $5.8 million (Q4 2025), and $6.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Sintx Technologies 17,274.80 -1.87 Mn 144,000.00 6.42 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.42 Mn
Dec 31, 2025 5.75 Mn
Sep 30, 2025 6.43 Mn
Jun 30, 2025 5.05 Mn
Mar 31, 2025 5.24 Mn
Dec 31, 2024 5.31 Mn
Sep 30, 2024 5.72 Mn
Jun 30, 2024 6.44 Mn
Mar 31, 2024 7.61 Mn
Dec 31, 2023 6.29 Mn
Sep 30, 2023 4.75 Mn
Jun 30, 2023 5.18 Mn
Mar 31, 2023 6.56 Mn
Dec 31, 2022 10.07 Mn
Sep 30, 2022 5.01 Mn
Jun 30, 2022 5.25 Mn
Mar 31, 2022 4.13 Mn
Dec 31, 2021 4.30 Mn
Sep 30, 2021 4.81 Mn
Jun 30, 2021 3.64 Mn